JP2023540591A5 - - Google Patents
Info
- Publication number
- JP2023540591A5 JP2023540591A5 JP2023515363A JP2023515363A JP2023540591A5 JP 2023540591 A5 JP2023540591 A5 JP 2023540591A5 JP 2023515363 A JP2023515363 A JP 2023515363A JP 2023515363 A JP2023515363 A JP 2023515363A JP 2023540591 A5 JP2023540591 A5 JP 2023540591A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- pharmaceutical preparation
- administration
- inhalation
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2014114.9 | 2020-09-08 | ||
| GBGB2014114.9A GB202014114D0 (en) | 2020-09-08 | 2020-09-08 | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid |
| PCT/GB2021/052302 WO2022053792A1 (en) | 2020-09-08 | 2021-09-07 | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540591A JP2023540591A (ja) | 2023-09-25 |
| JP2023540591A5 true JP2023540591A5 (cg-RX-API-DMAC7.html) | 2024-09-13 |
| JP7877300B2 JP7877300B2 (ja) | 2026-06-22 |
Family
ID=72841287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515363A Active JP7877300B2 (ja) | 2020-09-08 | 2021-09-07 | 全身性コルチコステロイドによる治療を受けているcopd患者におけるウイルス誘導性増悪を治療するための吸入インターフェロン-ベータの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230241177A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4210728A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7877300B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230066037A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116249545A (cg-RX-API-DMAC7.html) |
| GB (1) | GB202014114D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022053792A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6030609A (en) | 1995-05-19 | 2000-02-29 | Case Western Reserve University | Method and composition for treating paramyxovirus |
| GB0405634D0 (en) * | 2004-03-12 | 2004-04-21 | Univ Southampton | Anti-virus therapy for respiratory diseases |
| US7871603B2 (en) | 2007-05-18 | 2011-01-18 | Synairgen Research Limited | Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| JP2012512883A (ja) * | 2008-12-19 | 2012-06-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ウイルス感染の治療における上皮成長因子阻害剤の使用 |
| US9421243B2 (en) * | 2010-03-12 | 2016-08-23 | Synairgen Research Limited | Therapy for influenza like illness |
| WO2015157955A1 (en) * | 2014-04-17 | 2015-10-22 | Abbvie Inc. | Heterocyclic btk inhibit ors |
| GB201820659D0 (en) * | 2018-12-19 | 2019-01-30 | Imperial Innovations Ltd | Novel compostions and their use in therapy |
-
2020
- 2020-09-08 GB GBGB2014114.9A patent/GB202014114D0/en not_active Ceased
-
2021
- 2021-09-07 CN CN202180061630.8A patent/CN116249545A/zh active Pending
- 2021-09-07 JP JP2023515363A patent/JP7877300B2/ja active Active
- 2021-09-07 EP EP21777826.5A patent/EP4210728A1/en active Pending
- 2021-09-07 KR KR1020237011584A patent/KR20230066037A/ko active Pending
- 2021-09-07 US US18/024,648 patent/US20230241177A1/en active Pending
- 2021-09-07 WO PCT/GB2021/052302 patent/WO2022053792A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6297227B1 (en) | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines | |
| JP2004500429A (ja) | チオトロピウム及びロフレポニドを含む医薬用の組み合わせ | |
| JP2004500430A (ja) | ホルモテロール及びブデソニドを含有する医薬用の組み合わせ | |
| CN116033894A (zh) | 用于减少气道粘膜中的病毒复制的系统、方法和药物使用 | |
| JP2023520323A5 (cg-RX-API-DMAC7.html) | ||
| US20090022671A1 (en) | Treatment methods | |
| JP2026077677A (ja) | コロナウイルス感染症の処置のための方法 | |
| JP2023548647A (ja) | 吸入型血管作動性腸ポリペプチドの新しい投与計画 | |
| WO2015027848A1 (zh) | 含有帕拉米韦和/或其衍生物制剂的给药方法 | |
| EP3892275A1 (en) | Aerosolization of hcq or its metabolites for the treatment of lung infections | |
| JPH10500966A (ja) | 経口吸入もしくは吹き込みにより投与する為の化合物、及び組成物 | |
| CN113855685A (zh) | 糖皮质激素在制备治疗和/或预防呼吸道病毒感染的药物中的用途 | |
| JP2004500431A (ja) | (r,r)−ホルモテロール及びロフレポニドを含む医薬組成物 | |
| JP2023535710A5 (cg-RX-API-DMAC7.html) | ||
| JP7378425B2 (ja) | 肺サーファクタントおよびbpdの予防のためのステロイドを含む治療的組合せ | |
| CN116249545A (zh) | 在接受全身型皮质类固醇治疗的COPD患者中使用吸入型干扰素-β治疗病毒诱导的恶化 | |
| Kearns et al. | 88 Levofloxacin pharmacokinetics (PK) after administration of MP-376 (Levofloxacin inhalation solution; Aeroquin) in children with cystic fibrosis (CF) | |
| CN102670684A (zh) | 白薇总皂苷的应用 | |
| EP4507720A1 (en) | Alpha-1-antitrypsin for treating paramyxoviridae or orthomyxoviridae infections | |
| CN103690934B (zh) | 干扰素α与布地奈德的雾化吸入剂 | |
| HK40091740A (en) | Products of manufacture and methods for treating, ameliorating or preventing microbial infections | |
| WO2015027847A2 (zh) | 含有奥司他韦羧酸胍基类似体和/或其乙酯制剂的给药方法 | |
| CN102430112A (zh) | 干扰素α与硫酸沙丁胺醇的雾化吸入剂 | |
| WO2000015234A1 (en) | Compositions comprising corticosteroids for treating sinusitis or otitis media | |
| Ito et al. | 90 Inhibitory effects of RV1088, a novel narrow spectrum kinase inhibitor, on RSV infection in primary bronchial epithelial cells obtained from patients with cystic fibrosis |